Business Wire

THALES

21.9.2020 09:02:42 CEST | Business Wire | Press release

Share
Thales Empowers Organisations to Simplify the Discovery, Protection and Control of Sensitive Data

Thales today announced the launch of the CipherTrust Data Security Platform , the industry’s first unified data protection solution that enables organisations to discover, protect, and control their most sensitive data wherever it resides. The new platform helps solve key challenges they face today. These include data security complexity caused by multi-cloud adoption, evolving global and regional privacy regulations, as well as the risk of data breaches from external and internal threats.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200921005046/en/

Drawing from years of data protection innovation, Thales has built the CipherTrust Data Security Platform to seamlessly unify data discovery, classification and data protection, along with strong access controls and centralised key management. The ‘all-in-one’ platform combines the best of Thales’s Vormetric and SafeNet KeySecure technologies to give organisations the power to keep sensitive data secure on premises or in the cloud while reducing costs and maintaining the highest levels of compliance assurance.

“CipherTrust Data Security Platform unifies the most critical elements of data security – data discovery, protection and control – into one integrated platform, providing powerful tools to address the evolving global and regional privacy regulations as well as the uptick of cloud adoption intensified by remote working,” said Todd Moore, Vice President, Encryption Solutions, Thales . “In addition to the external challenges of data protection, our new platform also helps reduce the operational complexities many organisations face, especially as businesses work to recover from the effects of the COVID-19 pandemic. This evolution of security through simplicity is exactly what organisations require now and for the future.”

Solving the Complexity Problem

Highly-distributed workforces, evolving regulations and technologies, infinite data growth and the exploding use of multi-cloud services puts sensitive data at risk, and makes data security even more challenging. According to the 2020 Thales Data Threat Report - Global Edition, organisations use 29 different cloud services on average. Lack of visibility and operational complexity has resulted in organisations not knowing where all of their sensitive data is stored. This concern around complexity (identified as the number one barrier to security by nearly 40% of the 2020 Thales Data Threat Report-Global Edition respondents) is simplified with the CipherTrust Data Security Platform.

“Complexity is one of the main barriers to deploying data security more broadly, in part because overall data security remains fairly specialised and siloed, forcing enterprises to manage multiple vendors and point products,” said Garrett Bekker, Senior Research Analyst, Information Security at 451 Research, part of S&P Global Market Intelligence, in the report, ‘Thales unites KeySecure and Vormetric product lines under CipherTrust Data Security Platform.’ “With the launch of CipherTrust Data Security Platform, Thales is looking to simplify the delivery of data security with one of the broadest data security portfolios in the market, spanning most flavours of encryption (application, database, server, file), vaulted and vaultless tokenisation, masking, key management, cloud key management, and HSMs and most recently, data discovery.”

Discover and classify sensitive data in the cloud and on-premises

As more enterprise applications and data move to the cloud and companies seek to improve scalability and deliver remote capabilities for their workforce, IT organisations will be challenged to have a holistic view of their data. As part of the platform, CipherTrust Data Discovery and Classification enables organisations to discover and classify sensitive data, as well as remediate, from a single pane of glass. Organisations can understand risks, uncover gaps, and make better decisions about both third-party data sharing and cloud migration. In addition, the solution provides a comprehensive set of built-in classification templates for commonly requested data privacy and security regulations, such as the GDPR and California Consumer Privacy Act (CCPA), but is flexible enough to handle custom policies based on specific patterns and algorithms.

Protect sensitive data anywhere with advanced encryption and tokenisation

According to IDC, more than 175 zetabytes of data will be created by 2025, and today more than half of all corporate data is stored in the cloud. To address the complexity of where data is stored, the CipherTrust Data Security Platform offers strong capabilities for securing and controlling access to sensitive data in databases, files and containers. Specific technologies include:

  • CipherTrust Transparent Encryption – encrypts data across on-premises, cloud, database, file, and Big Data environments with comprehensive data access controls and detailed data access audit logging that can stop the most malicious attacks;
  • CipherTrust Database Protection – provides transparent column-level encryption of structured, sensitive data residing in databases, such as credit card, social security numbers, national ID numbers, passwords and email addresses;
  • CipherTrust Application Data Protection – offers APIs for developers to quickly add encryption and other crypto functions to their applications, while SecOps controls the encryption keys;
  • CipherTrust Tokenisation– offers application-level data tokenisation services in two convenient solutions that deliver customer flexibility--Vaultless Tokenisation with policy-based Dynamic Data Masking and Vaulted Tokenisation; and
  • CipherTrust Batch Data Transformation – provides static data masking services to remove sensitive data from production databases so compliance and security concerns are alleviated when sharing a database with third parties for analytics, testing, or other processing.

Control and centralise management of encryption keys

The accelerated adoption of encryption has led to the need to manage a far larger number of encryption keys across traditional data stores and multiple cloud environments. Proper management of encryption keys is paramount for data security because if keys are stolen, the encryption is rendered useless, and if they are lost the data is digitally shredded and cannot be recovered. This is why many organisations struggle with managing different key management solutions. CipherTrust Data Security Platform’s enterprise key management enables businesses to centrally manage and establish strong controls over encryption keys and policies for data encrypted on-premises and by cloud services. Specific technologies include:

  • CipherTrust Manager– centralises keys, management and data access policies for all CipherTrust Data Security Platform products and is available in both physical and virtual form factors that are up to FIPS 140-2 Level 3 compliant;
  • CipherTrust Cloud Key Manager – offers cloud bring you own key (BYOK) life cycle management for many Infrastructure, Platform- and Software as a Service cloud providers;
  • CipherTrust KMIP Server – centralises key management for the standard Key Management Interoperability Protocol (KMIP) commonly used across storage solutions; and,
  • CipherTrust TDE Key Manager – centralises key management for encryption found in Oracle, SQL, and Always Encrypted SQL.

Industry insight and views on the latest data security trends can be found on the Thales blog . Follow Thales on Twitter , LinkedIn , Facebook and YouTube .

About Thales

Thales (Euronext Paris: HO) is a global technology leader shaping the world of tomorrow today. The Group provides solutions, services and products to customers in the aeronautics, space, transport, digital identity and security, and defence markets. With 83,000 employees in 68 countries, Thales generated sales of €19 billion in 2019 (on a pro forma basis including Gemalto over 12 months).

Thales is investing in particular in digital innovations — connectivity, Big Data, artificial intelligence and cybersecurity — technologies that support businesses, organisations and governments in their decisive moments.

PLEASE VISIT

Thales Group

Security

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Datavault AI Announces Board of Directors Has Requested Management’s Complete Plan for Dividend Spin-Out of Acoustic Sciences Division into Stand-Alone Public Company7.5.2026 15:07:00 CEST | Press release

Initial planning calls for Data Sciences Division to focus efforts in cyber secure infrastructure with dedication in fintech and patented Information Data Exchange® (IDE®) Management will harness its API Media acquisition, robust patent portfolio, ADIO® Inaudible Tones, WiSA® and Dolby® partnerships to establish worldwide acoustic industry standards in high-definition wireless transmission, spatial-audio control and interoperability Plan includes API media’s stand-alone and renewed execution of WiSA semiconductor and software modules strategy with an R&D effort targeted to new robotic and drone applications Datavault AI Inc. (“Datavault AI” or the “Company”) (NASDAQ:DVLT), a pioneering technology licensing company seeking to redefine data valuation, monetization, and secure Web 3.0 experiences, today announced that Company management has commenced its evaluation of a potential dividend spin-out of the Company’s Acoustic Sciences division which includes its ADIO®, WiSA®, Event Citadel™,

Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® (ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis7.5.2026 14:50:00 CEST | Press release

First presentation of Week 24 results from TRuE-AD4 study in adults with moderate atopic dermatitis (AD) who had an inadequate response, intolerance or contraindication to topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs)at the 2026 EADV SymposiumThe vast majority of patients achieving EASI50 at Week 8 and continuing double-blind, as needed treatment with Opzelura® (ruxolitinib) cream through Week 24 demonstrated disease control, with 84.3% achieving EASI75 (a ≥75% improvement in the Eczema Area and Severity Index score from baseline) and 70.6% achieving IGA-TS (Investigator’s Global Assessment Treatment Success)Data support Type-II variation application submitted for ruxolitinib cream 1.5% for the treatment of adults with moderate AD in the European Union (EU), feedback expected in 1H 2026 Incyte (Nasdaq:INCY) today announced final 24-week data from the Phase 3 TRuE-AD4 study evaluating the efficacy and safety of Opzelura® (ruxolitinib) cream in adults with mode

Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings7.5.2026 14:03:00 CEST | Press release

Full data presented at ESOC 2026 further strengthen the clinical evidence supporting TIGERTRIEVER™ 13 for the treatment of distal vessel occlusion stroke — a segment representing nearly half of all ischemic strokes Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11th European Stroke Organisation Conference (ESOC) in Maastricht, Netherlands, showing that TIGERTRIEVER™ 13 can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke. These findings build on earlier results showing a threefold improvement in restoring blood flow compared with medical management alone (p<0.0001), with no cases of serious brain bleeding observed in the treatment group. “These results show we can now safely restore blood flow and suggest this will make a meaningful difference for the right patients,” said Jeffrey L

2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan7.5.2026 14:00:00 CEST | Press release

“Eat Where Locals Eat” Making authentic Japanese dining experiences accessible to global travelers through instant reservations at over 70,000 restaurants nationwide. Tabelog (https://tabelog.com/en/), one of Japan’s largest (*1) restaurant search and reservation services operated by Kakaku.com, Inc., has announced that its multilingual smartphone app (iOS/Android) for travelers visiting Japan has reached 2 million downloads (*2). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507560248/en/ 2M+ Downloads in 6 Months. The app also ranked #1 in downloads among Restaurant Search Apps in Japan for International Travelers (*3) in Taiwan, Hong Kong, South Korea, and the U.S., reflecting its immense popularity among global visitors. Download URL: https://tabelog-tourists.onelink.me/3eEh/iqkkho9r The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan For years, international visitors to Japan have

Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development7.5.2026 14:00:00 CEST | Press release

Altasciences, a fully integrated drug development solution company, andCertara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs. Fewer than half of preclinical drug candidates successfully reach first-in-human trials. Failures are driven by toxicity, poor pharmacokinetics, lack of efficacy, and challenges translating results from animals to humans. Many of these risks can be mitigated through a fully integrated model-informed drug development approach. Building on Altasciences’ Acceleration Platform, the integration of Certara’s strategic drug development services and biosimulation technology enables sponsors to establish proof of mechanism earlier, design more efficient studies, and make informed go/no-go decisions with greater confidence. By embedding modeling insights and digital workflows directly into development execution, study designs are optimized, dosing strategies

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye